InvestSMART

InhaleRx Limited (ASX: IRX) - Announcements

Current share price for IRX : $0.028 0.003 (12%)+

ASX company news and announcements for InhaleRx Limited (IRX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All InhaleRx Limited (IRX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than InhaleRx Limited (IRX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for InhaleRx Limited (IRX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Company Name and ASX Ticker - NX1 12 Feb 2026 6:20PM $0.025 $0.028 risen by 12%
- Proposed issue of securities - IRX 12 Feb 2026 5:26PM $0.025 $0.028 risen by 12%
- Clinical Development Outlook 2026 Presentation Slides 12 Feb 2026 2:07PM $0.024 $0.028 risen by 16.67%
- 2026 Clinical Development Outlook Webinar 9 Feb 2026 1:22PM $0.024 $0.028 risen by 16.67%
- Results of General Meeting 29 Jan 2026 6:33PM $0.025 $0.028 risen by 12%
- General Meeting Slides 29 Jan 2026 3:55PM $0.025 $0.028 risen by 12%
- Dec25 Quarterly Activities Report 29 Jan 2026 1:25PM $0.024 $0.028 risen by 16.67%
- Dec25 Appendix 4C Cash Flow Report 29 Jan 2026 1:16PM $0.024 $0.028 risen by 16.67%
- Application for quotation of securities - IRX 9 Jan 2026 9:12AM $0.023 $0.028 risen by 21.74%
- Allotment of the Balance of Tranche 1 Placement Shares 9 Jan 2026 9:12AM $0.023 $0.028 risen by 21.74%
- General Meeting - Access Letter 24 Dec 2025 12:28PM $0.023 $0.028 risen by 21.74%
- General Meeting - Sample Proxy 24 Dec 2025 12:27PM $0.023 $0.028 risen by 21.74%
- Notice of General Meeting 24 Dec 2025 12:27PM $0.023 $0.028 risen by 21.74%
- Change of Director's Interest Notice - Dr Ron Wise 24 Dec 2025 10:02AM $0.022 $0.028 risen by 27.27%
- Change of Director's Interest Notice - Sean Williams 24 Dec 2025 9:58AM $0.023 $0.028 risen by 21.74%
- Close of Entitlement Offer 23 Dec 2025 1:52PM $0.023 $0.028 risen by 21.74%
- Notification regarding unquoted securities - IRX 23 Dec 2025 11:38AM $0.023 $0.028 risen by 21.74%
- Application for quotation of securities - IRX 23 Dec 2025 11:37AM $0.023 $0.028 risen by 21.74%
- Cleansing Notice - Initial Placement Allocation 12 Dec 2025 11:41AM $0.025 $0.028 risen by 12%
- IRX Overview Presentation - SRX-25 and Nexalis 10 Dec 2025 10:24AM $0.025 $0.028 risen by 12%
- Application for quotation of securities - IRX 9 Dec 2025 9:27AM $0.025 $0.028 risen by 12%
- Initial Allotment of Placement Shares 9 Dec 2025 9:24AM $0.025 $0.028 risen by 12%
- Entitlement Offer - Ineligible Shareholders Letter 5 Dec 2025 5:31PM $0.026 $0.028 risen by 7.69%
- Dispatch of Entitlement Offer Prospectus 5 Dec 2025 5:30PM $0.026 $0.028 risen by 7.69%
- $12.6m Facility to Drive SRX-25 Development 4 Dec 2025 9:31AM $0.026 $0.028 risen by 7.69%

1 - 25 of 230 results

Page 1 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.